Projected Income Statement: Procter & Gamble Company

Forecast Balance Sheet: Procter & Gamble Company

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 24,279 26,361 22,978 24,952 24,196 24,240 22,928 20,833
Change - 8.58% -12.83% 8.59% -3.03% 0.18% -5.41% -9.14%
Announcement Date 29/7/22 28/7/23 30/7/24 29/7/25 29/7/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Procter & Gamble Company

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 3,156 3,062 3,322 3,773 4,409 4,424 4,251 4,317
Change - -2.98% 8.49% 13.58% 16.86% 0.35% -3.93% 1.55%
Free Cash Flow (FCF) 1 13,567 13,786 16,524 14,606 15,147 15,490 16,395 17,398
Change - 1.61% 19.86% -11.61% 3.7% 2.27% 5.84% 6.11%
Announcement Date 29/7/22 28/7/23 30/7/24 29/7/25 29/7/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Procter & Gamble Company

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 25.71% 25.42% 27.23% 27.65% 27.18% 27.32% 27.96% 28.3%
EBIT Margin (%) 22.21% 22.11% 23.78% 24.27% 23.55% 23.6% 24.09% 24.4%
EBT Margin (%) 22.44% 22.38% 22.32% 23.93% 23.41% 23.3% 24.14% 24.32%
Net margin (%) 18.38% 17.87% 17.7% 18.95% 18.44% 18.45% 19.21% 19.31%
FCF margin (%) 16.92% 16.81% 19.66% 17.33% 17.4% 17.45% 17.93% 18.41%
FCF / Net Income (%) 92.03% 94.08% 111.06% 91.44% 94.4% 94.55% 93.31% 95.34%

Profitability

        
ROA 12.47% 12.31% 13.39% 12.9% 12.75% 12.97% 13.39% 13.59%
ROE 31.53% 31.2% 30.48% 31.06% 30.11% 30.53% 31.74% 32.26%

Financial Health

        
Leverage (Debt/EBITDA) 1.18x 1.26x 1x 1.07x 1.02x 1x 0.9x 0.78x
Debt / Free cash flow 1.79x 1.91x 1.39x 1.71x 1.6x 1.56x 1.4x 1.2x

Capital Intensity

        
CAPEX / Current Assets (%) 3.94% 3.73% 3.95% 4.48% 5.07% 4.98% 4.65% 4.57%
CAPEX / EBITDA (%) 15.31% 14.69% 14.52% 16.19% 18.64% 18.24% 16.62% 16.14%
CAPEX / FCF (%) 23.26% 22.21% 20.1% 25.83% 29.11% 28.56% 25.93% 24.81%

Items per share

        
Cash flow per share 1 6.586 6.783 8.029 7.259 8.073 8.162 9.084 9.526
Change - 2.99% 18.37% -9.58% 11.21% 1.1% 11.3% 4.87%
Dividend per Share 1 3.523 3.681 3.829 4.076 4.259 4.396 4.592 4.806
Change - 4.47% 4.02% 6.47% 4.48% 3.22% 4.46% 4.64%
Book Value Per Share 1 19.57 19.8 20.45 21.3 22.42 23.64 24.6 25.8
Change - 1.18% 3.28% 4.15% 5.24% 5.45% 4.08% 4.84%
EPS 1 5.81 5.9 6.02 6.51 6.62 6.807 7.387 7.755
Change - 1.55% 2.03% 8.14% 1.69% 2.83% 8.52% 4.97%
Nbr of stocks (in thousands) 2,399,297 2,356,969 2,360,135 2,344,542 2,328,599 2,322,672 2,322,672 2,322,672
Announcement Date 29/7/22 28/7/23 30/7/24 29/7/25 29/7/26 - - -
1USD
Estimates
2027 *2028 *
P/E 21.3x 19.6x
PBR 6.14x 5.9x
EV / Sales 4.07x 3.94x
Yield 3.03% 3.16%

EPS & Dividend



Y-o-Y evolution of P/E

 

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
145.12USD
Average target price
160.61USD
Spread / Average Target
+10.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PG Stock
  4. Financials Procter & Gamble Company